How do I get GLP-1 medications in New York?

New York residents can get GLP-1 medications through licensed telehealth providers that ship compounded semaglutide or tirzepatide directly to New York addresses, or by seeing a local clinician in person and filling a brand-name prescription (Wegovy, Zepbound, Ozempic, Mounjaro) at a retail pharmacy. Telehealth providers that serve New York are listed above.

Is telehealth GLP-1 legal in New York?

Yes — telehealth prescribing of GLP-1 medications is legal in New York. Licensed providers can conduct an online evaluation, prescribe semaglutide or tirzepatide when clinically appropriate, and arrange delivery to your address through a partner pharmacy.

How much does compounded semaglutide cost in New York?

Compounded semaglutide pricing is set at the provider level, not the city level, and varies by dose and plan. See the pricing columns on each provider card above for the current monthly cost from providers that serve New York. Brand-name Wegovy and Zepbound retail list prices are $1,000-$1,350 per month without insurance.

Does insurance cover GLP-1s in New York?

Insurance coverage in New York follows New York plan-level rules. Most commercial plans cover Ozempic and Mounjaro for type 2 diabetes diagnoses, but coverage for Wegovy and Zepbound (the obesity-indicated versions) is much more limited and typically requires prior authorization. Check your plan's formulary for the specific drug and indication you need.

What's the cheapest way to get GLP-1s in New York?

The lowest-cost route for New York residents is usually compounded semaglutide or tirzepatide through telehealth, averaging around $229/month in New York — well below brand-name Wegovy ($1,349/mo) or Zepbound ($1,086/mo) without insurance. Compare current pricing from providers serving New York above, or check if your insurance covers a brand-name option first.

Does New York Medicaid cover weight-loss GLP-1s?

New York Medicaid coverage for GLP-1 weight-loss medication is currently: Diabetes + obesity (with prior auth). Ozempic and Mounjaro are generally covered for type 2 diabetes, while the obesity-indicated versions (Wegovy, Zepbound) typically require prior authorization or aren't covered at all, depending on the plan.

How many GLP-1 providers serve New York?

181 GLP-1 telehealth and in-person providers currently serve New York residents, based on our tracked pricing and availability data. See the full ranked list above, or browse the A-Z index for every provider that ships to New York.

GLP-1 Weight Loss in New York (2026)

181 GLP-1 telehealth providers ship to New York, New York. Compounded semaglutide averages $229/month — same active ingredient as Wegovy and Ozempic, a fraction of the cost.

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Featured Partners · New York

Featured GLP-1 providers serving New York

No insurance needed
reader-supported

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Top pick
7.6
Maximus
Compounded from
$249.99/mo
Save $1,099.01/mo vs Wegovy
Get started →
8.3
Found
Compounded from
$99/mo
Save $1,250/mo vs Wegovy
Get started →
7.4
Breeze Meds
Compounded from
$199/mo
Save $1,150/mo vs Wegovy
Get started →
6.2
Wellorithm
Compounded from
$147/mo
Save $1,202/mo vs Wegovy
Get started →
8.2
Gala
Compounded from
$149/mo
Save $937/mo vs Zepbound
Get started →
6.9
TMates
Compounded from
$249/mo
Save $1,100/mo vs Wegovy
Get started →

Provider	Compounded from	Save vs brand
7.6MaximusTop pick	$249.99/mo	Save $1,099.01/mo	Get started →
8.3Found	$99/mo	Save $1,250/mo	Get started →
7.4Breeze Meds	$199/mo	Save $1,150/mo	Get started →
6.2Wellorithm	$147/mo	Save $1,202/mo	Get started →
8.2Gala	$149/mo	Save $937/mo	Get started →
6.9TMates	$249/mo	Save $1,100/mo	Get started →

See all 181 GLP-1 providers serving New York ↓

New York at a Glance

New York population

8,336,817

City proper

Metro-area population

19,500,000

Wider telehealth market

New York obesity rank

#41 of 50

1 = highest prevalence

New York avg. compounded price

$229/mo

Semaglutide, cash-pay

About GLP-1 Access in New York

New York is largest city in the United States, located in New York with a population of approximately 8.3 million. Telehealth is legal in New York, and licensed GLP-1 providers can prescribe semaglutide or tirzepatide and ship directly to New York ZIP codes. Prices, formulary availability, and specific provider state coverage vary — confirm with the provider before starting.

The New York metro area brings the wider telehealth-serviceable population to roughly 19,500,000 residents, extending beyond the city's 8,336,817 city-proper population.

New York's adult obesity rate is approximately 27.3% based on CDC Behavioral Risk Factor Surveillance System data^[2], and state rankings are published in CDC's Adult Obesity Facts^[3]. New York has lower obesity prevalence than most states (#41 of 50), but telehealth still widens access beyond New York's major metros for New York residents who don't live near a specialist. Before starting treatment, it's worth understanding what the clinical trials actually showed about GLP-1 side effects.

New York Medicaid covers GLP-1s for obesity with prior authorization, so New York residents on Medicaid should start by asking their prescriber to document a qualifying BMI and comorbidities for the PA request.

Looking beyond New York? See all GLP-1 providers in New York.

Browse by Medication

Semaglutide in New York

Best providers, pricing, and how to get started.

Tirzepatide in New York

Best providers, pricing, and how to get started.

All GLP-1 Providers Serving New York

CoreAge Rx

Verified partner

Best for: best overall value

8.3

CoreAge Rx offers LegitScript-verified compounded semaglutide and tirzepatide with free 2-day shipping to all 50 states. Backed by licensed physicians and 24/7 support, it delivers the most competitive pricing in the compounded GLP-1 space.

Score Breakdown

Value25%

8.5

Effectiveness25%

8.5

User Experience15%

8.5

Trust & Safety15%

7.8

Accessibility10%

Support10%

8.4

Pros

✓LegitScript certified — rigorous pharmacy standards
✓Free 2-day shipping nationwide
✓Both semaglutide and tirzepatide available
✓Lowest per-month pricing in the compounded segment
✓24/7 support team
✓All 50 states covered

Cons

✗Compounded only — no brand-name Ozempic or Wegovy
✗Newer brand with fewer independent reviews than legacy players

Starting from $99/moRead full review →

Visit CoreAge Rx →

Enhance MD

Verified partner

Best for: lab-monitored compounded GLP-1 with mandatory video visit

8.2

Enhance MD pairs compounded semaglutide and tirzepatide with mandatory baseline metabolic labs at Quest Diagnostics and a synchronous video visit with a board-certified clinician — a more rigorous onboarding than the async-only compounded GLP-1 model most telehealth providers use. Three tiers (Core semaglutide, Advanced tirzepatide, Elite combined) plus $100-off-first-order intro pricing ($112 first month on Core with code SUMMER100).

Score Breakdown

Value25%

Effectiveness25%

User Experience15%

8.5

Trust & Safety15%

Accessibility10%

8.5

Support10%

8.9

Pros

✓Baseline and ongoing metabolic labs (CMP, lipids, TSH, HbA1c) at Quest every 6 months — rare for compounded GLP-1
✓Mandatory video visit with a US-licensed MD or NP before your first prescription — not a pure questionnaire model
✓Three tiers, including a combined semaglutide + tirzepatide Elite plan ($322/mo) for patients plateaued on one GLP-1
✓Uses LegitScript-certified 503A pharmacies (Tru Meds Rx, Strive Pharmacy, Pharmacy Hub)
✓Intro pricing via $100 off your first order (code SUMMER100): $112 Core, $180 Advanced, $222 Elite first month
✓Unlimited clinician messaging and dose-adjustment support included

Cons

✗Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro
✗Not available in 10 states: AL, AR, GA, HI, LA, MS, MO, SC, TN, WV
✗Mandatory lab work adds 5–10 days to onboarding vs async-only competitors
✗No insurance accepted — cash pay, HSA/FSA eligible
✗Intro discount applies only to the first order — ongoing rates are $212–$322/mo on 12-month plans, or $249–$379/mo month-to-month

Starting from $112/moRead full review →

Visit Enhance MD →

bmiMD

Verified partner

Best for: mainstream telehealth GLP-1 access

8.1

Medical weight loss clinic offering GLP-1 prescriptions through telehealth.

Score Breakdown

Value25%

Effectiveness25%

User Experience15%

7.5

Trust & Safety15%

7.3

Accessibility10%

8.5

Support10%

Pros

✓Both semaglutide and tirzepatide available

Cons

✗Cheapest advertised rates require a 12-month prepaid plan — month-to-month is $129 for semaglutide and $139 for sermorelin injection

Starting from $99/moRead full review →

Visit bmiMD →

Pallas Health

Verified partner

Best for: the most complete public disclosure of pharmacies and prescribing physicians we have found

8.1

Pallas Health is a telehealth platform operated by Brentmoor, Inc. offering compounded semaglutide and tirzepatide alongside brand-name Wegovy, Ozempic, Zepbound and Mounjaro. Compounded plans average $199 and $299 a month with provider care, check-ins and messaging included and no separate membership fee, and the price stays the same at every dose. Its clinical disclosures page is unusually complete: two named advising physicians with verifiable NPIs, the clinical partner Lion MD, six named partner pharmacies, and coverage in all 50 states plus DC.

Score Breakdown

Value25%

7.5

Effectiveness25%

User Experience15%

8.5

Trust & Safety15%

Accessibility10%

Support10%

Pros

✓Names six partner pharmacies with phone numbers and websites, the most complete pharmacy disclosure we have recorded.
✓Publishes two advising physicians with NPI numbers you can verify yourself in the federal NPPES registry.
✓Price stays the same at every dose, and provider care, check-ins and messaging are included with no membership fee.
✓Offers brand-name Wegovy, Ozempic, Zepbound and Mounjaro alongside compounded options, and serves all 50 states plus DC.

Cons

✗Billed $597 every 12 weeks, not monthly; at 4.33 cycles a year the true cost is about $216/mo, above the $199 advertised.
✗The homepage claims "200,000+ patients" while the clinical page describes a July 2026 launch and existing waitlist patients.
✗Canceling after a payment deducts third-party processing costs plus a $5 fee per refunded payment.
✗In states requiring a live video visit a $60 deposit is taken at checkout, and it may be retained if you abandon the intake.

Starting from $139/moRead full review →

Visit Pallas Health →

RxSpan MD

Verified partner

Best for: physician-led, pharmacy-transparent compounded GLP-1 with brand-name options

8.1

RxSpan MD is a physician-led telehealth practice founded by Dr. John Diaz, a board-certified plastic surgeon, offering compounded GLP-1 weight loss — semaglutide and tirzepatide from $249/mo, as injections or oral capsules — plus brand-name Wegovy, Zepbound and Ozempic. It's unusually transparent: it names its 503A pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma) and medical group, ships free, and includes unlimited 24/7 support. Available in all 50 states.

Score Breakdown

Value25%

Effectiveness25%

8.5

User Experience15%

7.5

Trust & Safety15%

9.3

Accessibility10%

8.5

Support10%

8.9

Pros

✓Physician-led — founded by Dr. John Diaz, a board-certified plastic surgeon with 20+ years' experience
✓Compounded semaglutide and tirzepatide from $249/mo (injection or oral capsules), plus brand-name Wegovy, Zepbound and Ozempic
✓Names its 503A pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma) and medical group
✓LegitScript-certified (#50405601); free expedited shipping and unlimited 24/7 support included
✓Available in all 50 states via a 2-minute assessment

Cons

✗Compounded pricing ($249 semaglutide / $329 tirzepatide) sits mid-to-high versus the cheapest telehealth options
✗Brand-name GLP-1 is priced steeply (Wegovy $1,349, Ozempic $1,299, Zepbound $1,069)
✗Multi-vertical practice (also hair, sexual health, longevity), not weight-loss-only
✗Legal entity name isn't published on the site

Editorial score · methodology

$88/mosemaglutide

$157/motirzepatide

CompoundedSemaglutideTirzepatideNAD+SermorelinLegitScript Verified

Get Started Read full Sunlight review →

Browse all 302 providers with undisclosed New York coverage A–Z

In-Person vs Telehealth in New York

Patients in New York have two main paths to GLP-1 treatment: an in-person obesity medicine or bariatric program, or a licensed telehealth provider that ships to New York addresses. In-person programs are generally preferable for patients with complex medical needs, those pursuing bariatric surgery, or patients whose insurance covers a brand-name anti-obesity GLP-1 and requires in-person documentation. Telehealth is generally preferable for patients seeking cash-pay compounded semaglutide or tirzepatide from a 503A compounding pharmacy^[5]. Medicaid and commercial insurance coverage of anti-obesity GLP-1s in New York varies by plan^[4].

Cost of GLP-1 Medications in New York

Average compounded semaglutide (New York)^[1]

$229/month

Brand-name Wegovy in New York typically costs $1,349/month without insurance, while Zepbound runs $1,086/month. Compounded semaglutide through telehealth providers averages $229/month in New York, representing savings of more than $13,000 per year. For a full breakdown of every low-cost option, read our cheapest way to get GLP-1s without insurance guide. If you're deciding between the two paths, see our compounded vs. branded GLP-1 decision guide.

Other Cities in New York

Comparing options beyond New York? GLP-1 telehealth providers ship statewide, so these New York cities have their own dedicated pricing and provider breakdowns:

Buffalo GLP-1 providers →Rochester GLP-1 providers →Syracuse GLP-1 providers →

Frequently Asked Questions

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Semaglutide · Drugs and brands
Tirzepatide · Drugs and brands
Compounded GLP-1 · Pharmacy and drug forms
503A pharmacy · Pharmacy and drug forms
PCAB accreditation · Pharmacy and drug forms
Prior authorization (PA) · Insurance and regulatory
Off-label use · Insurance and regulatory
FDA Drug Shortage List · Insurance and regulatory

Compare All Providers Calculate Savings

Get New York Price Alerts

Be the first to know about new GLP-1 providers and price changes in New York.

Sources & methodology — as of August 2026

1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
2.CDC BRFSS — Adult Obesity Prevalence Maps by State (Behavioral Risk Factor Surveillance System)— Centers for Disease Control and Prevention.
3.CDC — State Obesity Rankings and Adult Obesity Facts— Centers for Disease Control and Prevention.
4.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
5.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.